RPS14 and neoplasm: Our results further demonstrated that specific RPS14 ablation in LY6A+ stem cells greatly attenuated the tumor-promoting effects of F. nucleatum, resulting in a substantial reduction in tumor burden within the colon (Figure 4, J and K).